Having a “white knight” hanging around to give your company a nice infusion of cash is always a nice incentive to taking a bit of a risk. New market entry is always a bit of a risk, even if you have an established product to enter that market with. Not being 100% sure of how that new market will react – socially and financially - to a new product is always the risk. But if the “white knight” is willing to support in more than just a monetary way, the chances of sizable profit can be increased considerably.

Unigene Labs Inc., a biopharmaceutical company, works to develop and market peptide and other related pharmaceuticals. The company currently has an estimated 55% market share of the prescription nasal congestion marketplace and is entering Phase III trials with a new calcintonin product.

The company has been having moderate successes with its Fortical product, although

If you want to know about the hottest, most undervalued stocks before the rest of the investment community, then add our “Ones to Watch” to your radar. We are constantly adding stocks to the list as new opportunities appear. One of our latest “Ones to Watch” realized a 115% increase in share price.

If you would like to view our current “Ones to Watch”, as well as add the list to your favorites, then please visit www.gotstocks.qualitystocks.net where you can find the hottest stocks with excellent potential to succeed in the short and long term future.

Let us hear your thoughts below: